Please join Pear Therapeutics as they:

•             Discuss their FDA-authorized, prescription digital therapeutics (PDTs) reSET and reSET-O for Substance Use Disorder (SUD) and Opioid Use Disorder, respectively

•             Cover key clinical and economic data showing improved clinical outcomes with reduced health care costs

•             Discuss data related to the incarcerated population. 

 This will be followed by a panel discussion covering how correctional systems have integrated these PDTs into their treatment programs.

There is no CE for this session.